Pharmafile Logo
Pharmafocus logo
Advanced Search

safety testing

Showing 1 posts of 1 posts found.

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026
Biotechnology, bit.bio, drug discovery, myriamed, safety testing

bit.bio has partnered with German biotechnology company myriamed to offer cryopreserved human induced pluripotent stem cell (iPSC)-derived cardiomyocytes for drug …

News
The Gateway to Local Adoption Series

Latest content

Migraine annual economic and quality-of-life burden in UK

October 1, 2026

bit.bio expands human heart cell portfolio through myriamed partnership

September 30, 2026

Phoenix Labs acquires Kent Pharma

September 29, 2026

Astoriom acquires Sampled’s UK stability storage operations

September 28, 2026

Alcami appoints Will Isom to lead laboratory services sales

September 28, 2026